Wang Changjian, Cao Yipeng, Yang Qi, Wang Xinyue, Yang Zhiying, Yang Jingjing, Li Xinru, Li Bin, Wang Yuefei, Zhang Min
State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Front Microbiol. 2024 Dec 18;15:1510665. doi: 10.3389/fmicb.2024.1510665. eCollection 2024.
The unavoidable propagation of the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has underscored the urgent requirement for efficacious therapeutic agents. The dried fruit of Retz., namely Chebulae Fructus, is widely used for treating bacterial and viral infectious diseases, which was witnessed to perform anti-SARS-CoV-2 activity in recommended Chinese patent medicine.
SARS-CoV-2 main protease (M) and papain-like protease (PL) present essential effects on SARS-CoV-2 replication and transcription, considering as the attractive targets for therapeutic intervention. In this study, we focused on the dual-target to obtain broad-spectrum antiviral candidates from Chebulae Fructus.
The identified compounds from Chebulae Fructus were used to build a library in a previous study, which were evaluated by molecular docking to screen potential antiviral agents. The SARS-CoV-2 M and PL were expressed in cells and purified. Fluorescence resonance energy transfer (FRET) and surface plasmon resonance (SPR) were utilized to verify the affinity with dual targets. SARS-CoV-2 wild-type, Omicron BA.5 and Omicron EG.5 variants were employed to validate their antiviral activities . Molecular dynamics simulation was conducted via Gromacs 2022 software in 500 ns to unveil the conformation stability.
Targeting on M and PL, eight compounds were screened as the potential dual-target inhibitors in molecular docking. In FRET and SPR assays, 1,2,3,4,6-penta--galloyl--D-glucose (PGG) and 1,2,3,6-tetra--galloyl--D-glucose (TGG) showed good inhibitory activities with IC values ranging from 1.33 to 27.37 μM, and affinity with values ranging from 0.442 to 0.776 μM. Satisfactorily, both PGG and TGG display antiviral activity with EC values ranging from 3.20 to 37.29 μM, suggesting as the promising candidates against SARS-CoV-2. In molecular dynamics simulation study, the complexes of M-PGG, M-TGG, PL-PGG, and PL-TGG exhibited stability over 500 ns period, unveiling the potential interactions.
PGG and TGG are the promising dual-target inhibitors of SARS-CoV-2, which may avoid drug resistance and have a good development prospect. The outcomes of this study provide an effective strategy to systematically explore the antiviral bioactive compounds from Chebulae Fructus.
由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病(COVID-19)不可避免地传播,凸显了对有效治疗药物的迫切需求。诃子(Retz.)的干燥果实,即诃子,广泛用于治疗细菌和病毒感染性疾病,在推荐的中成药中被证实具有抗SARS-CoV-2活性。
SARS-CoV-2主要蛋白酶(M)和木瓜样蛋白酶(PL)对SARS-CoV-2的复制和转录起着关键作用,被视为有吸引力的治疗干预靶点。在本研究中,我们聚焦于这一双靶点,从诃子中获取广谱抗病毒候选物。
在之前的一项研究中,从诃子中鉴定出的化合物被用于构建一个文库,通过分子对接进行评估以筛选潜在的抗病毒药物。SARS-CoV-2的M和PL在细胞中表达并纯化。利用荧光共振能量转移(FRET)和表面等离子体共振(SPR)来验证与双靶点的亲和力。采用SARS-CoV-2野生型、奥密克戎BA.5和奥密克戎EG.5变体来验证它们的抗病毒活性。通过Gromacs 2022软件进行500纳秒的分子动力学模拟,以揭示构象稳定性。
针对M和PL,在分子对接中筛选出8种化合物作为潜在的双靶点抑制剂。在FRET和SPR分析中,1,2,3,4,6-五没食子酰基-β-D-葡萄糖(PGG)和1,2,3,6-四没食子酰基-β-D-葡萄糖(TGG)表现出良好的抑制活性,IC值范围为1.33至27.37μM,亲和力值范围为0.442至0.776μM。令人满意的是,PGG和TGG均显示出抗病毒活性,EC值范围为3.20至37.29μM,表明它们是抗SARS-CoV-2的有前景的候选物。在分子动力学模拟研究中,M-PGG、M-TGG、PL-PGG和PL-TGG复合物在500纳秒内表现出稳定性,揭示了潜在的相互作用。
PGG和TGG是有前景的SARS-CoV-2双靶点抑制剂,可能避免耐药性,具有良好的开发前景。本研究结果为系统探索诃子中的抗病毒生物活性化合物提供了一种有效策略。